Waters Corporation (WAT) Stock

Waters Corporation (WAT) is a Technology stock trading at $376.75 (as of 2026-07-09), with a market capitalization of $36.99B and a trailing P/E of 82.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Waters Corporation provides analytical workflow systems through its Waters and TA segments, including instruments for liquid chromatography and mass spectrometry, thermal analysis, rheometry, and calorimetry, along with chromatography columns, consumables, software that interfaces with its instruments, and post-warranty service plans. Its technologies are used in areas such as drug discovery and development, protein analysis, nutritional safety, and environmental testing, and in evaluating materials and formulations for industrial and healthcare uses.

Understand Waters Corporation: how it makes money

Waters Corporation makes and sells analytical instruments and related solutions, including liquid chromatography and mass spectrometry systems, plus thermal analysis and related software-based offerings, and it earns money from both products and ongoing services such as post-warranty service plans.

Because Waters sells sophisticated analytical instruments (product revenue) and also supports them with post-warranty services and other support products, its profit engine is tied to sustaining an installed base and maintaining recurring service and support demand alongside new instrument sales.

Revenue by segment (latest quarter)
Waters$0.9B
TA$0.4B

Business quality (Mixed): Good business description and clear two-segment structure (Waters, TA), but the input set provides operating metrics mostly through revenue labels, and TA segment revenue is not explicitly listed (only Waters revenue is given).

Valuation: At 47× earnings, WAT trades 21% below the Measuring & Control Equipment average (60×). Note: one-time items can distort reported P/E.

Bull case

  • Two-segment platform across measurement workflows: Waters operates through two segments, Waters and TA, and provides analytical workflow solutions plus instruments and support products, including chromatography columns and post-warranty service plans.
  • Recurring elements tied to installed equipment: The company sells post-warranty service plans and other support products, which can help stabilize revenue alongside new instrument sales.

Bear case

  • Operating profitability appears weak: The company reported an operating margin of -3.7% for the provided period, indicating losses at the operating level.
  • Revenue growth can be pressured across cycles and regions: Reported revenue is split across major geographies (Americas, Europe, Asia) and includes pharma-related end markets, so demand shifts can affect reported organic revenue and service revenue.
Valuation — source: SEC EDGAR (first-party)
Price$376.75
Market Cap$36.99B
P/E Ratio82.3
EV / EBITDA58.6
Price / Book2.42
Price / Sales9.81
FCF Yield-0.1%
DCF Value (model)$108.17
DCF Upside vs Price-71.3%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$3.17B
Net Margin20.3%
Revenue Growth (YoY)91.5%
EPS Growth (YoY)-142.6%
FCF Growth (YoY)-118.0%
Financial Health — source: SEC EDGAR
Altman Z-Score13.05 (safe)
Piotroski F-Score4/9 (moderate)
Valuation vs Sector & Industry
Stock P/E82.3
Sector P/E (Technology)33.6
Industry P/E (Measuring & Control Equipment)58.0
vs Sector145.0%
vs Industry41.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($2.84B)
Institutional Holders Tracked10
Congressional Trades (recent)10
Company
SectorTechnology
IndustryMeasuring & Control Equipment
CEOUdit Batra
Employees7,600
CountryUS
IPO Date1995-11-17

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Agilent Technologies, Inc. (A)
  • Illumina, Inc. (ILMN)
  • Mettler-Toledo International Inc. (MTD)
  • Revvity, Inc. (RVTY)
  • Bruker Corporation (BRKR)
  • Bio-Rad Laboratories, Inc. (BIO)
  • Avantor, Inc. (AVTR)
  • 10x Genomics, Inc. (TXG)
WAT earnings history · WAT institutional & insider holders · WAT KPIs & operating metrics · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-07-09.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.